1 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024374)
|
2 |
ClinicalTrials.gov (NCT00976820) Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age. U.S. National Institutes of Health.
|
3 |
ClinicalTrials.gov (NCT04850898) Study of SAB-176 in Healthy Adult Participants. U.S. National Institutes of Health.
|
4 |
ClinicalTrials.gov (NCT01587131) DNA-based Influenza Vaccine in the Elderly. U.S. National Institutes of Health.
|
5 |
Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. Clin Cancer Res. 2010 Jul 1;16(13):3495-506.
|
6 |
Clinical pipeline report, company report or official report of Medicago Inc.
|
7 |
Clinical pipeline report, company report or official report of Vical.
|
8 |
ClinicalTrials.gov (NCT01172054) Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults. U.S. National Institutes of Health.
|
|
|
|
|
|
|